Home › Type 2 Diabetes › Indiana
Type 2 Diabetes clinical trials in Indiana
19 studies for Type 2 Diabetes are looking for participants at sites in Indiana.
Cities in Indiana
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- MediSphere Medical Research Center, LLC, Evansville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Indiana Medical Research Institute, Indianapolis
- Franciscan Physician Network- Indiana Heart Physicians, Indianapolis
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- DM Clinical Research - Indianapolis, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Evansville
- AURORA-2 Clinical Site, Indianapolis
- AURORA-2 Clinical Site, Valparaiso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- American Health Network - Avon, Avon
- Midwest Cardiovascular Research and Education Foundation, Elkhart
- American Health Network - Greenfield, Greenfield
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- AES - DRS - Synexus Clinical Research US, Inc. - Evansville, Evansville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Investigators Research Group, Brownsburg
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Midwest Inst For Clin Res, Indianapolis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Evansville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Riley Hospital For Children, Indianapolis
RecruitingPhase 3
Ages 10 to 18 · All sexes · Updated Sep 9, 2026 · NCT07282613AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- American Health Network of IN LLC_Franklin, Franklin
- American Health Network of Indiana, LLC_Greenfield, Greenfield
- American Health Network of IN LLC, Muncie
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Evansville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- The South Bend Clinic, South Bend
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT07527650A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Center for Diabetes and Metabolic Diseases Indiana University, Indianapolis
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Indiana University, Indianapolis
Recruiting
Ages 14 to 75 · All sexes · Updated Aug 3, 2026 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Indiana University, Bloomington
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07521475Drug Interaction Potential of Pro-Inflammatory Conditions
- Indiana University Hospital, Indianapolis
RecruitingObservational study
Ages 12 to 99 · All sexes · Updated Jan 22, 2026 · NCT07360938Heat Therapy in Type 2 Diabetes
- Purdue University, West Lafayette
RecruitingPhase 1
Ages 55 and older · All sexes · Updated Sep 19, 2024 · NCT06596967From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.